Gain Therapeutics leads the way in AI-driven drug discovery for complex diseases (original). It is different from other AI platforms because it focuses on targets that are traditionally "undruggable" and does not require extensive data. This platform's ability to develop compounds and enter them into clinical trials represents a major milestone in drug discovery.